Moderna logo

Moderna Income Statement

Revenue, expenses, and profitability over time

Moderna generated $2.2B in trailing twelve-month revenue, down 0.3% year-over-year. Net income was -$3.2B with a -143.55% net margin. Gross margin stands at 22.11% and operating margin at -153.35%. Diluted EPS is $-8.15, which grew 0.1% year-over-year. Based on the Q1 2026 filing.

Latest FilingQ1 2026
Report Date2026-05-01
Market Cap$18.9B
ROE-36.56%

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense-$64.0M$7.0M$7.0M$13.0M$27.0M$9.0M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$966.0M$108.0M$142.0M$1.0B$678.0M$389.0M